Roche cordially invites you to attend our Industry Workshop
during the ACOG75 Annual Clinical & Scientific Meeting.
How Alaska is Revolutionizing Cervical Cancer Detection with HPV Primary Screening and Dual-Stain Triage
Hear from Bethany Berry, Senior Nurse Midwife and Women’s Health Advocate, and Dr. James Tiesinga, Laboratory Medical Director and Statewide Oversight Pathologist, as they discuss the implementation and patient impact of Primary HPV screening and dual-stain triage in their Alaskan community.
Bethany R. Berry, CNM, MSN
Senior Nurse Midwife &
Women’s Health Advocate
James J. Tiesinga, M.D.
Laboratory Medical Director &
Statewide Oversight Pathologist
Workshop details
Saturday, May 2, 12 p.m. to 12:45 p.m.
Walter E. Washington Convention Center
801 Allen Y. Lew Place NW
Washington, DC 20001
Room 207A
Save the date
Click the button below and complete the form to have a calendar hold emailed to you.
Workshop topics
- Gain awareness of existing disparities in cervical cancer incidence and outcomes among Alaska Native communities, and understand how primary screening for human papillomavirus can help address gaps in early detection and prevention.
- Review the key principles of implementation science and ways this framework can work within health organizations to adopt Primary HPV screening and dual-stain triage as an evidence-based strategy to detect HPV infections and cervical precancers to prevent cervical cancer.
- Understand methods and tools used in a Tribal Health Organization to integrate HPV testing into system workflows (clinics, labs, EHR, staff, and consumers).
- Review the successes and challenges experienced while implementing Primary HPV screening, HPV self-collection, and dual-stain triage in a large public health system that serves both urban and rural communities in Alaska.
Save the date
Complete the form to have a calendar hold emailed to you.